Carregant...

Inhibitors of Calcium Oxalate Crystallization for the Treatment of Oxalate Nephropathies

Calcium oxalate (CaOx) crystal‐induced nephropathies comprise a range of kidney disorders, for which there are no efficient pharmacological treatments. Although CaOx crystallization inhibitors have been suggested as a therapeutic modality already decades ago, limited progress has been made in the di...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Adv Sci (Weinh)
Autors principals: Kletzmayr, Anna, Mulay, Shrikant R., Motrapu, Manga, Luo, Zhi, Anders, Hans‐Joachim, Ivarsson, Mattias E., Leroux, Jean‐Christophe
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7175250/
https://ncbi.nlm.nih.gov/pubmed/32328427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/advs.201903337
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!